[1]
|
曹毛毛, 陈万青. GLOBOCAN 2020全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 63-69.
|
[2]
|
Ikushima, S., Ono, R., Fukuda, K., Sakayori, M., Awano, N. and Kondo, K. (2016) Trousseau’s Syndrome: Cancer-Associated Thrombosis. Japanese Journal of Clinical Oncology, 46, 204-208. https://doi.org/10.1093/jjco/hyv165
|
[3]
|
Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O’Fallon, W.M. and Melton, L.J. (2000) Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study. Archives of Internal Medicine, 160, 809-815. https://doi.org/10.1001/archinte.160.6.809
|
[4]
|
Levitan, N., Dowlati, A., Remick, S.C., Tahsildar, H.I., Sivinski, L.D., Beyth, R. and Rimm, A.A. (1999) Rates of Initial and Recurrent Thromboembolic Disease among Patients with Malignancy versus Those Without Malignancy. Risk Analysis Using Medicare Claims Data. Medicine (Baltimore), 78, 285-291.
https://doi.org/10.1097/00005792-199909000-00001
|
[5]
|
顾毅. 肿瘤与静脉血栓形成的关系研究进展[J]. 中国癌症杂志, 2002(1): 87-90.
|
[6]
|
Lip, G.Y., Chin, B.S. and Blann, A.D. (2002) Cancer and the Prothrombotic State. The Lancet Oncology, 3, 27-34.
https://doi.org/10.1016/S1470-2045(01)00619-2
|
[7]
|
Gordon, S.G. and Benson, B. (1989) Analysis of Serum Cancer Procoagulant Activity and Its Possible Use as a Tumor Marker. Thrombosis Research, 56, 431-440. https://doi.org/10.1016/0049-3848(89)90256-9
|
[8]
|
Dolan, S. and Fitch, M. (2007) The Management of Venous Thromboembolism in Cancer Patients. British Journal of Nursing, 16, 1308-1312. https://doi.org/10.12968/bjon.2007.16.21.27715
|
[9]
|
Zwicker, J.I., Furie, B.C. and Furie, B. (2007) Can-cer-Associated Thrombosis. Critical Reviews in Oncology/Hematology, 62, 126-136. https://doi.org/10.1016/j.critrevonc.2007.01.001
|
[10]
|
Noble, S.I., Shelley, M.D., Coles, B., Williams, S.M., Wil-cock, A., Johnson, M.J. and Association for Palliative Medicine for Great Britain and Ireland (2008) Management of Venous Thromboembolism in Patients with Advanced Cancer: A Systematic Review and Meta-Analysis. The Lancet Oncology, 9, 577-584.
https://doi.org/10.1016/S1470-2045(08)70149-9
|
[11]
|
Tawil, N., Bassawon, R. and Rak, J. (2019) Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis. Semi-nars in Thrombosis and Hemostasis, 45, 373-384.
https://doi.org/10.1055/s-0039-1687891
|
[12]
|
王昊, 袁建松. 消化道恶性肿瘤并发静脉血栓栓塞的分子机制与风险评估[J]. 中国分子心脏病学杂志, 2021, 21(6): 4380-4383. https://doi.org/10.16563/j.cnki.1671-6272.2021.12.021
|
[13]
|
Nash, G.F., Turner, L.F., Scully, M.F. and Kakkar, A.K. (2002) Platelets and Cancer. The Lancet Oncology, 3, 425-430.
https://doi.org/10.1016/S1470-2045(02)00789-1
|
[14]
|
Jain, S., Zuka, M., Liu, J., Russell, S., Dent, J., Guerrero, J., Forsyth, J., Maruszak, B., Gartner, T.K., Felding-Habermann, B. and Ware, J. (2007) Platelet Glycoprotein Ib Alpha Supports Experimental Lung Metastasis. Proceedings of the National Academy of Sciences of the United States of Amer-ica, 104, 9024-9028.
https://doi.org/10.1073/pnas.0700625104
|
[15]
|
雷静, 张珲娉, 韩伟, 谭姣, 马永红, 刘莉, 吴志新. 消化道恶性肿瘤高通量基因测序的生物统计分析[J]. 现代肿瘤医学, 2021, 29(23): 4118-4121.
|
[16]
|
Ades, S., Kumar, S., Alam, M., Goodwin, A., Weckstein, D., Dugan, M., Ashikaga, T., Evans, M., Verschraegen, C. and Holmes, C.E. (2015) Tumor Oncogene (KRAS) Status and Risk of Venous Thrombosis in Patients with Metastatic Colorectal Cancer. Journal of Thrombosis and Haemostasis, 13, 998-1003. https://doi.org/10.1111/jth.12910
|
[17]
|
Dunbar, A., Bolton, K.L., Devlin, S.M., Sanchez-Vega, F., Gao, J., Mones, J.V., et al. (2021) Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid Tumors. Blood, 137, 2103-2113.
https://doi.org/10.1182/blood.2020007488
|
[18]
|
邱天, 郭曙光, 方伟, 苏宏斌, 陈匡荣, 张铠. 下肢深静脉血栓发病的高危因素[J]. 中华医学杂志, 2013, 93(29): 2279-2282.
|
[19]
|
王辉. 消化系统恶性肿瘤并发静脉血栓栓塞症危险因素分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
https://doi.org/10.27162/d.cnki.gjlin.2020.004368
|
[20]
|
Königsbrügge, O., Lötsch, F., Zielinski, C., Pabinger, I. and Ay, C. (2014) Chronic Kidney Disease in Patients with Cancer and Its Association with Occurrence of Venous Thromboembolism and Mortality. Thrombosis Research, 134, 44-49. https://doi.org/10.1016/j.thromres.2014.04.002
|
[21]
|
鲜枫, 谢忠. 恶性肿瘤相关性血栓栓塞研究进展[J]. 中华实用诊断与治疗杂志, 2016, 30(5): 432-434.
https://doi.org/10.13507/j.issn.1674-3474.2016.05.006
|
[22]
|
雷亚飞. 以静脉血栓形成为早期临床表现的消化道恶性肿瘤的临床特点研究[J]. 疾病监测与控制, 2019, 13(6): 436-437+440.
|
[23]
|
Walker, A.J., Card, T.R., West, J., Crooks, C. and Grainge, M.J. (2013) Incidence of Venous Thromboembolism in Patients with Cancer—A Cohort Study Using Linked United Kingdom Databases. European Journal of Cancer, 49, 1404-1413. https://doi.org/10.1016/j.ejca.2012.10.021
|
[24]
|
Ferroni, P., Riondino, S., Guadagni, F. and Roselli, M. (2013) Im-pact of Chemotherapy on Venous Thromboembolism: Comment to: Regional Lymph Node Metastases Are a Strong Risk Factor for Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study. Haematologica, 98, e153-e154.
https://doi.org/10.3324/haematol.2013.092528
|
[25]
|
Ahlbrecht, J., Dickmann, B., Ay, C., Dunkler, D., et al. (2012) Tumor Grade Is Associated with Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology, 30, 3870-3875. https://doi.org/10.1200/JCO.2011.40.1810
|
[26]
|
Faiz, A.S., Khan, I., Beckman, M.G., Bockenstedt, P., Heit, J.A., et al. (2015) Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thrombosis Research, 136, 535-541.
https://doi.org/10.1016/j.thromres.2015.06.036
|
[27]
|
Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H. and Francis, C.W. (2008) Development and Validation of a Predictive Model for Chemotherapy-Associated Thrombosis. Blood, 111, 4902-4907.
https://doi.org/10.1182/blood-2007-10-116327
|
[28]
|
张倩倩. 恶性肿瘤合并静脉血栓栓塞的危险因素分析[D]: [硕士学位论文]. 新乡: 新乡医学院, 2020.
https://doi.org/10.27434/d.cnki.gxxyc.2020.000230
|
[29]
|
Ay, C., Vormittag, R., Dunkler, D., Simanek, R., Chiriac, A.L., Drach, J., et al. (2009) D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology, 27, 4124-4129. https://doi.org/10.1200/JCO.2008.21.7752
|
[30]
|
Masuda, T., Hayashi, N., Iguchi, T., Ito, S., Eguchi, H. and Mi-mori, K. (2016) Clinical and Biological Significance of Circulating Tumor Cells in Cancer. Molecular Oncology, 10, 408-417. https://doi.org/10.1016/j.molonc.2016.01.010
|
[31]
|
Bettegowda, C., Sausen, M., Leary, R.J., et al. (2014) Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, 6, 224ra24.
|
[32]
|
Hoshino, A., Costa-Silva, B., Shen, T.L., et al. (2015) Tumour Exosome Integrins Determine Organo-tropic Metastasis. Nature, 527, 329-335.
|
[33]
|
Allard, W.J., Matera, J., Miller, M.C., Repollet, M., Connelly, M.C., Rao, C., Tibbe, A.G., Uhr, J.W. and Terstappen, L.W. (2004) Tumor Cells Circulate in the Peripheral Blood of All Major Car-cinomas but Not in Healthy Subjects or Patients with Nonmalignant Diseases. Clinical Cancer Research, 10, 6897-6904.
https://doi.org/10.1158/1078-0432.CCR-04-0378
|
[34]
|
Ignatiadis, M., Riethdorf, S., Bidard, F.C., et al. (2014) In-ternational Study on Inter-Reader Variability for Circulating Tumor Cells in Breast Cancer. Breast Cancer Research, 16, R43.
|
[35]
|
欧洋. 胃癌患者外周血循环肿瘤细胞检测及临床意义的研究[D]: [硕士学位论文]. 济南: 济南大学, 2019.
|
[36]
|
Hiraiwa, K., Takeuchi, H., Hasegawa, H., et al. (2008) Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers. Annals of Surgical Oncology, 15, 3092-3100.
https://doi.org/10.1245/s10434-008-0122-9
|
[37]
|
Okabe, H., Tsunoda, S., Hosogi, H., Hisamori, S., Tanaka, E., Tanaka, S. and Sakai, Y. (2015) Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer. Annals of Surgical Oncology, 22, 3954-3961.
https://doi.org/10.1245/s10434-015-4483-6
|
[38]
|
Lee, A.M., Tormoen, G.W., Kanso, E., et al. (2012) Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow. Frontiers in Oncology, 2, Article No. 108. https://doi.org/10.3389/fonc.2012.00108
|
[39]
|
Kasthuri, R.S., Taubman, M.B., Mackman, N., et al. (2009) Role of Tissue Factor in Cancer. Journal of Clinical Oncology, 27, 4834-4838. https://doi.org/10.1200/JCO.2009.22.6324
|
[40]
|
Malik, G., Knowles, L.M., Dhir, R., et al. (2010) Plasma Fibron-ectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion. Cancer Research, 70, 4327-4334.
https://doi.org/10.1158/0008-5472.CAN-09-3312
|
[41]
|
王晓康, 袁锦权. 肺癌患者术后血液高凝状态与外周血循环肿瘤细胞的相关性分析[J]. 中国当代医药, 2021, 28(29): 13-16.
|
[42]
|
汤雨. 老年前列腺癌患者外周血循环肿瘤细胞与临床特征的相关性研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2017.
|